AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sitaxa M XR 100+500 Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitaxa M XR 100+500 Tablet

Diabex Duo XR 100/500mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications, such as renal impairment and vision loss, and may lessen the risk of cardiovascular events. Diabex Duo XR 100/500mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, glucose levels, and other concurrent medications. Taking the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle significantly impacts blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; patients should be educated on its recognition and management. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women require medical consultation before use. Potential drug interactions necessitate disclosing all current medications to ensure patient safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout the treatment period.

Primary Ingredients of Sitaxa M XR 100+500 Tablet

No text was provided to rewrite.

Uses of Sitaxa M XR 100+500 Tablet

Managing type 2 diabetes

Major Benefits of Sitaxa M XR 100+500 Tablet:

Always follow your physician's instructions or consult the product label for proper administration. Consume Sitaxa M XR 100+500 Tablets with a meal.

Common Side effects of Sitaxa M XR 100+500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaxa M XR 100+500 Tablet:

Follow your physician's instructions or consult the product labeling for administration guidelines. Ingest Sitaxa M XR 100+500 Tablets with a meal.

How Sitaxa M XR 100+500 Tablet works:

Sitaxa M XR 100+500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitaxa M XR 100+500 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaxa M XR 100+500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaxa M XR 100+500 Tablet while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms manifest.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaxa M XR 100+500 Tablet cautiously, potentially requiring dosage modification. Physician consultation is essential. For individuals with severe kidney disease, Sitaxa M XR 100+500 Tablet is contraindicated. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitaxa M XR 100+500 Tablet is likely inadvisable for individuals with hepatic impairment and should be forgone. A physician's consultation is recommended.

What if you forget to take Sitaxa M XR 100+500 Tablet :

Should you forget a dose of Sitaxa M XR 100+500 Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaxa M XR 100+500 Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitaxa M XR 100+500 Tablet

Sitaxa M XR 100+500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitaxa M XR 100+500 Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and urinary issues), cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaxa M XR 100+500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaxa M XR 100+500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaxa M XR 100+500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (Sitaxa M XR 100+500 Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitaxa M XR 100+500 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. It helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not for use in individuals under 18.
Sitaxa M XR 100+500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitaxa M XR 100+500 Tablets are contraindicated in patients allergic to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitaxa M XR 100+500 Tablet is unsafe due to an increased risk of lactic acidosis.
Sitagliptin + Metformin (Sitaxa M XR 100+500 Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitaxa M XR 100+500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaxa M XR 100+500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaxa M XR 100+500 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaxa M XR 100+500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaxa M XR 100+500 Tablet and alcohol is unsafe due to the increased risk of lactic acidosis.
Sitagliptin + Metformin (Sitaxa M XR 100+500 Tablet) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitaxa M XR 100+500 Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues (including numbness, tingling in extremities, weakness, and balance problems), urinary problems, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaxa M XR 100+500 Table...
189